[一名糖尿病患者使用益生菌后发生鼠李糖乳杆菌败血症：病例报告]
[Lactobacillus rhamnosus septicemia in a diabetic patient associated with probiotic use: a case report].
作者信息
Zein E F, Karaa S, Chemaly A, Saidi I, Daou-Chahine W, Rohban R
机构信息
Service de médecine interne et de maladies infectieuses, Hôpital Saint-Joseph, Centre Médical R&A Najjar, Beyrouth Dora, Liban.
出版信息
Ann Biol Clin (Paris). 2008 Mar-Apr;66(2):195-8. doi: 10.1684/abc.2008.0210.
BACKGROUND
probiotic agents are increasingly used as over the counter drugs for the treatment of a variety of inflammatory and infectious conditions. The rationale of their use seems to restore a friendly bacterial flora in the gut. Complications of probiotic use, although rarely reported, can occur.
OBSERVATION
we describe the case of a 54-year-old diabetic woman, who developed Lactobacillus rhamnosus septicemia while she was using probiotic oral treatment. Lactobacillus is a major component of probiotic agents. Her infection resolved after amoxicilline administration.
DISCUSSION
this case highlights the complication of probiotic use, and perhaps the patient's predispositions to develop such complications.
背景
益生菌制剂越来越多地被用作非处方药物，用于治疗各种炎症和感染性疾病。使用它们的基本原理似乎是恢复肠道内友好的细菌菌群。虽然益生菌使用的并发症很少被报道，但仍可能发生。
观察
我们描述了一名54岁糖尿病女性的病例，她在接受益生菌口服治疗时发生了鼠李糖乳杆菌败血症。乳杆菌是益生菌制剂的主要成分。给予阿莫西林治疗后，她的感染得到了缓解。
讨论
该病例突出了益生菌使用的并发症，以及患者发生此类并发症的易感性。
Zotero 插件